Science Explorer Back to mapMap
Discussion
Company · Norwood · United States

Corbus Pharmaceuticals (United States)

corbuspharma.comROR OpenAlex
Research works
44
▲ 11% vs 2018-21
Citations
394
9.0 per fractional work
Top-10% rate
18.6%
all institutions 10.0%
Open access
44%
world 40%
International
17%
world 18%
Corbus Pharmaceuticals (United States)

Not ranked overall: Corbus Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Corbus Pharmaceuticals (United States) work in?

In all years, 37% of research at Corbus Pharmaceuticals (United States) is in Health Sciences, 27% in Physical Sciences. Its largest fields are Medicine (36%), Engineering (20%), Psychology (10%). It does 1.5× the world's share of Health Sciences.

Health Sciences: 16 fractional works · 37.0% of its workMedicine: 16 fractional works · 35.6% of its workPharmacology: 3 fractional works · 5.8% of its workEpidemiology: 2 fractional works · 5.5% of its workPathology and Forensic Medicine: 2 fractional works · 4.0% of its workOncology: 2 fractional works · 3.6% of its workDermatology: 1 fractional works · 3.0% of its workSurgery: 1 fractional works · 2.8% of its workImmunology and Allergy: 1 fractional works · 2.3% of its workRheumatology: 1 fractional works · 1.8% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.6% of its workPsychiatry and Mental health: 1 fractional works · 1.6% of its workPhysiology: 0 fractional works · 0.9% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.5% of its workUrology: 0 fractional works · 0.4% of its workEmergency Medicine: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.2% of its workGastroenterology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 1.1% of its workEmergency Medical Services: 0 fractional works · 1.1% of its workDentistry: 0 fractional works · 0.3% of its workPeriodontics: 0 fractional works · 0.3% of its workPhysical Sciences: 12 fractional works · 26.6% of its workEngineering: 9 fractional works · 20.2% of its workSafety, Risk, Reliability and Quality: 2 fractional works · 4.9% of its workCivil and Structural Engineering: 2 fractional works · 4.7% of its workOcean Engineering: 1 fractional works · 1.6% of its workControl and Systems Engineering: 1 fractional works · 1.3% of its workAerospace Engineering: 1 fractional works · 1.3% of its workMechanics of Materials: 1 fractional works · 1.3% of its workBuilding and Construction: 0 fractional works · 1.1% of its workBiomedical Engineering: 0 fractional works · 1.0% of its workElectrical and Electronic Engineering: 0 fractional works · 0.8% of its workAutomotive Engineering: 0 fractional works · 0.8% of its workMechanical Engineering: 0 fractional works · 0.6% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.6% of its workComputational Mechanics: 0 fractional works · 0.3% of its workComputer Science: 1 fractional works · 1.9% of its workSignal Processing: 0 fractional works · 0.8% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.5% of its workArtificial Intelligence: 0 fractional works · 0.4% of its workInformation Systems: 0 fractional works · 0.3% of its workEnvironmental Science: 1 fractional works · 1.6% of its workEnvironmental Engineering: 0 fractional works · 0.8% of its workPollution: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 1 fractional works · 1.4% of its workMaterials Chemistry: 0 fractional works · 0.8% of its workPolymers and Plastics: 0 fractional works · 0.4% of its workGeneral Materials Science: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.8% of its workGeophysics: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.8% of its workAstronomy and Astrophysics: 0 fractional works · 0.8% of its workSocial Sciences: 9 fractional works · 20.5% of its workPsychology: 4 fractional works · 10.2% of its workClinical Psychology: 3 fractional works · 7.9% of its workGeneral Psychology: 1 fractional works · 1.5% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.8% of its workArts and Humanities: 2 fractional works · 4.6% of its workLiterature and Literary Theory: 1 fractional works · 2.3% of its workPhilosophy: 1 fractional works · 1.5% of its workConservation: 0 fractional works · 0.8% of its workSocial Sciences: 1 fractional works · 2.3% of its workPolitical Science and International Relations: 1 fractional works · 1.5% of its workSociology and Political Science: 0 fractional works · 0.8% of its workDecision Sciences: 1 fractional works · 1.5% of its workManagement Science and Operations Research: 0 fractional works · 0.8% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.5% of its workEconomics and Econometrics: 0 fractional works · 0.8% of its workFinance: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.0% of its workBusiness, Management and Accounting: 0 fractional works · 0.5% of its workManagement Information Systems: 0 fractional works · 0.3% of its workStrategy and Management: 0 fractional works · 0.3% of its workLife Sciences: 7 fractional works · 15.8% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 9.8% of its workMolecular Biology: 2 fractional works · 5.5% of its workBiotechnology: 1 fractional works · 2.3% of its workCancer Research: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.5% of its workCell Biology: 0 fractional works · 0.4% of its workEndocrinology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 1 fractional works · 1.9% of its workPlant Science: 0 fractional works · 0.8% of its workSoil Science: 0 fractional works · 0.8% of its workFood Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.8% of its workToxicology: 1 fractional works · 1.4% of its workPharmaceutical Science: 0 fractional works · 0.4% of its workImmunology and Microbiology: 1 fractional works · 1.8% of its workImmunology: 1 fractional works · 1.8% of its workNeuroscience: 0 fractional works · 0.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.6% of its workALL ITS WORKCorbusPharmaceuticals…44fractional works, all years
Life Sciences16%Physical Sciences27%Health Sciences37%Social Sciences21%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine1635.6%
    2. Health Professions01.1%
    3. Dentistry00.3%
    1. Engineering920.2%
    2. Computer Science11.9%
    3. Environmental Science11.6%
    4. Materials Science11.4%
    5. Earth and Planetary Sciences00.8%
    6. Physics and Astronomy00.8%
    1. Psychology410.2%
    2. Arts and Humanities24.6%
    3. Social Sciences12.3%
    4. Decision Sciences11.5%
    5. Economics, Econometrics and Finance11.5%
    6. Business, Management and Accounting00.5%
    1. Biochemistry, Genetics and Molecular Biology49.8%
    2. Agricultural and Biological Sciences11.9%
    3. Pharmacology, Toxicology and Pharmaceutics11.8%
    4. Immunology and Microbiology11.8%
    5. Neuroscience00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.62× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.35× its world share, 0 worksImmunology and Micro…Neuroscience: 0.32× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.98× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.09× its world share, 0 worksComputer ScienceEngineering: 0.62× its world share, 2 worksEngineeringMaterials Science: 0.59× its world share, 0 worksMaterials ScienceDentistry: 1.71× its world share, 0 worksDentistryMedicine: 2.65× its world share, 8 worksMedicineArts and Humanities: 0.72× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.43× its world share, 0 worksBusiness, Management…Psychology: 2.31× its world share, 1 worksPsychologySocial Sciences: 0.49× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.0×. Every wedge is a field page.

All 13 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics3.98×0 works
  2. Immunology and Microbiology3.35×0 works
  3. Medicine2.65×8 works
  4. Biochemistry, Genetics and Molecular Biology2.62×2 works
  5. Psychology2.31×1 works
  6. Dentistry1.71×0 works
  7. Arts and Humanities0.72×0 works
  8. Engineering0.62×2 works
  9. Materials Science0.59×0 works
  10. Social Sciences0.49×1 works
  11. Business, Management and Accounting0.43×0 works
  12. Neuroscience0.32×0 works
  13. Computer Science0.09×0 works

Who are the top researchers at Corbus Pharmaceuticals (United States)?

Ranked on the quality score, Nancy Dgetluck and Scott Constantine lead among researchers whose main affiliation is Corbus Pharmaceuticals (United States).

  1. 1 Nancy Dgetluck United States · #986,610 worldwide 847 citations · 35 works
  2. 2 Scott Constantine United States · #1,291,197 worldwide 689 citations · 35 works
All ranked researchers at Corbus Pharmaceuticals (United States)

What are the most cited papers from Corbus Pharmaceuticals (United States)?

The most cited paper from Corbus Pharmaceuticals (United States) is "TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death" (Kageaki Kuribayashi, Gabriel S. Krigsfeld, Wenge Wang et al., 2008), with 131 citations. Next come "Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis" (104) and "Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study" (82).

Most cited papers
#PaperReleasedCitations
1 TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death Kageaki Kuribayashi, Gabriel S. Krigsfeld, Wenge Wang et al. · Cancer Biology & Therapy Open access Dec 2008 131
2 Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis Robert Spiera, Laura Kathleen Hummers, Lorinda Chung et al. · Arthritis & Rheumatology Open access 26 Apr 2020 104
3 Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study Elena Schiopu, Soumya Swarup Chatterjee, Vivien M Hsu et al. · Arthritis Research & Therapy Open access 7 Jun 2016 82
4 Potent Anti‐Inflammatory and Pro‐Resolving Effects of Anabasum in a Human Model of Self‐Resolving Acute Inflammation Madhur P. Motwani, Frances Jenkins Bennett, Paul C. Norris et al. · Clinical Pharmacology & Therapeutics Open access 14 Dec 2017 76
5 Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis James F. Chmiel, Patrick A. Flume, Damian G. Downey et al. · Journal of Cystic Fibrosis Open access Oct 2020 68
All 45 most cited papers, with filters and sorting

Which keywords describe research at Corbus Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Autoantibodies, Treatment, Cancer Risk, Interstitial Lung Disease, Dermatomyositis, Inflammatory Myopathies, Inflammation and Neuroprotection.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 34 words, with their numbers
  1. Autoantibodies4▲ 39×4 topics
  2. Treatment4▲ 6.5×7 topics
  3. Inflammation3▲ 3.1×9 topics
  4. Cancer Risk3▲ 24×3 topics
  5. Interstitial Lung Disease3▲ 109×2 topics
  6. Dermatomyositis2▲ 347×1 topic
  7. Inflammatory Myopathies2▲ 347×1 topic
  8. Meta-Analysis2▲ 8.3×2 topics
  9. Neurological Disorders2▲ 6.6×2 topics
  10. Neuroprotection2▲ 12×2 topics
  11. Cannabinoid Receptors2▲ 151×1 topic
  12. Endocannabinoid System2▲ 151×1 topic
  13. Angiogenesis2▲ 9.5×3 topics
  14. Cancer2▲ 2.5×5 topics
  15. Fibrosis2▲ 18×3 topics
  16. Smoke Control2▲ 150×1 topic
  17. Tunnel Fires2▲ 150×1 topic
  18. Immunosuppressive Therapy1▲ 16×2 topics
  19. Immunotherapy1▲ 4.7×2 topics
  20. Neoliberalism1▲ 8.4×3 topics
  21. Psychotherapy Outcome1▲ 73×1 topic
  22. Therapeutic Alliance1▲ 73×1 topic
  23. Cell Adhesion1▲ 30×2 topics
  24. Epidemiology1▼ 0.62×6 topics
  25. Bacterial Therapy1▲ 52×1 topic
  26. Contemporary Fiction1▲ 233×1 topic
  27. Epithelial-Mesenchymal Transition1▲ 28×2 topics
  28. Focal Adhesion Kinase1▲ 40×1 topic
  29. History1▲ 2.9×2 topics
  30. Integrins1▲ 40×1 topic
  31. Neuroscience1▲ 7.2×2 topics
  32. Postmodernism1▲ 53×1 topic
  33. Social Sciences1▲ 14×2 topics
  34. Tumor Targeting1▲ 17×1 topic

Which research topics does Corbus Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Cell Adhesion Molecules Research, Inflammatory Myopathies and Dermatomyositis, Cannabis and Cannabinoid Research and Cancer Research and Treatments.

Cell Adhesion Molecules …1Cell Adhesion Molecules Research: 1 fractional worksInflammatory Myopathies …1Inflammatory Myopathies and Dermatomyositis: 1 fractional worksCannabis and Cannabinoid…1Cannabis and Cannabinoid Research: 1 fractional worksCancer Research and Trea…1Cancer Research and Treatments: 1 fractional worksCancer Cells and Metastasis: 1 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksAutoimmune Bullous Skin …0Autoimmune Bullous Skin Diseases: 0 fractional worksPharmacology and Obesity Treatment: 0 fractional worksUrinary and Genital Oncology Studies: 0 fractional worksGalectins and Cancer Biology: 0 fractional works
Immunology and AllergyEpidemiologyPharmacologyBiotechnology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cell Adhesion Molecules Research Immunology and Allergy 1 works
  2. 2 Inflammatory Myopathies and Dermatomyositis Epidemiology 1 works
  3. 3 Cannabis and Cannabinoid Research Pharmacology 1 works
  4. 4 Cancer Research and Treatments Biotechnology 1 works
  5. 5 Cancer Cells and Metastasis Oncology 1 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
  7. 7 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 0 works
  8. 8 Pharmacology and Obesity Treatment Pharmacology 0 works
  9. 9 Urinary and Genital Oncology Studies Surgery 0 works
  10. 10 Galectins and Cancer Biology Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.5%not open55.5%

World: 40% of research is openly available.

with international co-authors17.4%domestic only82.6%

World: 18% is written across borders.

How has Corbus Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 11% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Corbus Pharmaceuticals (United States) as a percentage of every work published that year, 0.000041% in 2024.

still counting0.00010%0.00020%0.00030%Corbus Pharmaceuticals (United States)0.000018% in 202519801990200020102020

Fractional works of Corbus Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Norwood

All research institutions in Norwood

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Corbus Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.